The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
The Proline Cycle As a Potential Cancer Therapy Target
Open accessAbstract
Interest in how proline contributes to cancer biology is expanding because of the emerging role of a novel proline metabolic cycle in cancer cell survival, proliferation, and metastasis. Proline biosynthesis and degradation involve the shared intermediate Δ 1 -pyrroline-5-carboxylate (P5C), which forms l -glutamate-γ-semialdehyde (GSAL) in a reversible non-enzymatic reaction. Proline is synthesized from glutamate or ornithine through GSAL/P5C, which is reduced to proline by P5C reductase (PYCR) in a NAD(P)H-dependent reaction. The degradation of proline occurs in the mitochondrion and involves two oxidative steps catalyzed by proline dehydrogenase (PRODH) and GSAL dehydrogenase (GSALDH). PRODH is a flavin-dependent enzyme that couples proline oxidation with reduction of membrane-bound quinone, while GSALDH catalyzes the NAD + -dependent oxidation of GSAL to glutamate. PRODH and PYCR form a metabolic relationship known as the proline–P5C cycle, a novel pathway that impacts cellular growth and death pathways. The proline–P5C cycle has been implicated in supporting ATP production, protein and nucleotide synthesis, anaplerosis, and redox homeostasis in cancer cells. This Perspective details the structures and reaction mechanisms of PRODH and PYCR and the role of the proline–P5C cycle in cancer metabolism. A major challenge in the field is to discover inhibitors that specifically target PRODH and PYCR isoforms for use as tools for studying proline metabolism and the functions of the proline–P5C cycle in cancer. These molecular probes could also serve as lead compounds in cancer drug discovery targeting the proline–P5C cycle.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Phyre2 web portal for protein modeling, prediction and analysis
Kelley, L. A., Mezulis, S., Yates, C. M., Wass, M. N., & Sternberg, M. J. E. (2015) · Nature Protocols · doi:10.1038/nprot.2015.053 · Cited by 9,652
The resurgence of covalent drugs
Singh, J., Petter, R. C., Baillie, T. A., & Whitty, A. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3410 · Cited by 1,873
Metabolic recycling of ammonia via glutamate dehydrogenase supports breast cancer biomass
Spinelli, J. B., Yoon, H., Ringel, A. E., Jeanfavre, S., Clish, C. B., & Haigis, M. C. (2017) · Science · doi:10.1126/science.aam9305 · Cited by 468
Olivares, O., Mayers, J. R., Gouirand, V., Torrence, M. E., Gicquel, T., Borge, L., Lac, S., Roques, J., Lavaut, M.-N., Berthezène, P., et al. (2017) · Nature Communications · doi:10.1038/ncomms16031 · Cited by 413
Proline oxidase functions as a mitochondrial tumor suppressor in human cancers
Liu, Y., Borchert, G. L., Donald, S. P., Diwan, B. A., Anver, M., & Phang, J. M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1223 · Cited by 132
PYCR2 Mutations cause a lethal syndrome of microcephaly and failure to thrive
Zaki, M. S., Bhat, G., Sultan, T., Issa, M., Jung, H., Dikoglu, E., Selim, L., G. Mahmoud, I., Abdel‐Hamid, M. S., Abdel‐Salam, G., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24678 · Cited by 45
Cited by
The PI3K–AKT network at the interface of oncogenic signalling and cancer metabolism
Hoxhaj, G., & Manning, B. D. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0216-7 · Cited by 2,137
The metabolism of cancer cells during metastasis
Bergers, G., & Fendt, S.-M. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-020-00320-2 · Cited by 950
Self-citationRobinson, J. L., Kocabaş, P., Wang, H., Cholley, P.-E., Cook, D., Nilsson, A., Anton, M., Ferreira, R., Domenzain, I., Billa, V., et al. (2020) · Science Signaling · doi:10.1126/scisignal.aaz1482 · Cited by 442
Proline metabolism as regulatory hub
Alvarez, M. E., Savouré, A., & Szabados, L. (2022) · Trends in Plant Science · doi:10.1016/j.tplants.2021.07.009 · Cited by 399
Proline metabolic dynamics and implications in drought tolerance of peanut plants
Furlan, A. L., Bianucci, E., Giordano, W., Castro, S., & Becker, D. F. (2020) · Plant Physiology and Biochemistry · doi:10.1016/j.plaphy.2020.04.010 · Cited by 255
Self-citation
Metadata
- Authors
- Tanner, J. J., Fendt, S.-M., & Becker, D. F.
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2018-04-12
- Volume
- 57
- Issue
- 25
- Pages
- 3433-3444
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W2797927489
- Cited by
- 160
- References
- 6
- FWCI
- 6.10
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.